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Background: Osteoporosis, a disease characterized by low bone mineral density (BMD), is an important health
problem in Mexico. BMD is a highly heritable trait, with heritability estimates of 50-85%. Several candidate genes
have been evaluated to identify those involved in BMD variation and the etiology of osteoporosis. This study
investigated the possible association of single-nucleotide polymorphisms (SNPs) in the MEF2C, SOST and JAG1genes
with bone mineral density (BMD) variation in postmenopausal Mexican-Mestizo women.
Methods: Four hundred unrelated postmenopausal women were included in the study. Risk factors were recorded
and BMD was measured in total hip, femoral neck and lumbar spine using dual-energy X-ray absorptiometry. In an
initial stage, a total of twenty-five SNPs within or near SOST gene and seven SNPs in the JAG1 gene were genotyped
using a GoldenGate assay. In a second stage, three MEF2C gene SNPs were also genotyped and SOST and JAG1
gene variants were validated. Real time PCR and TaqMan probes were used for genotyping.
Results: Linear regression analyses adjusted by age, body mass index and ancestry estimates, showed that five
SNPs in the SOST gene were significantly associated with BMD in total hip and femoral neck but not lumbar spine.
The lowest p value was 0.0012, well below the multiple–test significance threshold (p = 0.009), with mean effect size
of −0.027 SD per risk allele. We did not find significant associations between BMD and MEF2C/JAG1 gene variants
[rs1366594 “A” allele: β = 0.001 (95% CI −0.016; 0.017), P = 0.938; rs2273061 “G” allele: β = 0.007 (95% CI −0.007;
0.023), p = 0.409].
Conclusions: SOST polymorphisms may contribute to total hip and femoral neck BMD variation in Mexican
postmenopausal women. Together, these and prior findings suggest that this gene may contribute to BMD
variation across populations of diverse ancestry.
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Osteoporosis (OP) is a common skeletal disease characte-
rized by reduced bone mass, microarchitecture deterio-
ration, and a reduction in bone mineral density (BMD),
leading to increased bone fragility and susceptibility to
fracture [1]. OP is a serious public health problem in
Mexico causing up to 30,000 osteoporotic fractures a year,
and an annual health service expenditure of about $97* Correspondence: rvelazquez@inmegen.gob.mx
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article, unless otherwise stated.million in 2006 [2]. While multiple risk factors influence
the pathogenesis of osteoporosis, genetic factors play an
important role in BMD variation. Heritability of this trait
is high, as twin and family studies show that genetic fac-
tors account for approximately 50% to 85% of BMD [3].
Several candidate genes have been evaluated to assess
their role in BMD variation and the etiology of osteopo-
rosis, mainly in populations of European and Asian an-
cestry [4-6]. Research has focused on the Wnt/β-catenin
signaling pathway, which is known to play a major role
in bone remodeling [7]. The SOST (sclerostin) gene en-
codes the sclerostin protein, which binds to LRP5/6 co-Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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both osteocytes and osteoblasts [8,9]. Several SOST single
nucleotide polymorphisms (SNPs) have been associated
with BMD variation [6,10-12]. Moreover, the MEF2C
(myocyte enhancer factor 2C) gene, another member of
the Wnt-signaling pathway [13], is known to play an im-
portant role in determining bone density and mediating
inflammatory effects in bone [14] and Mef2C is the main
transcriptional factor responsible for ECR5-dependent
Sost expression in the adult skeleton of mice [15]. Within
this gene, rs1366594 has been associated with Femoral
Neck (FN) BMD in Europeans, and with Total Hip (TH)
BMD in populations from East-Asia [4,5]; while
rs119510131, was found to be significantly associated with
forearm BMD in the meta-analysis of 6,584 individuals of
European and Mexican American descent [16].
In another pathway, Jagged-1 has been found to in-
duce human mesenchymal stem cell (hMSC) osteoblast
differentiation through canonical Notch signaling [17]. A
genome-wide association study (GWAS) reported that
the rs2273061 polymorphism within the JAG1 (jagged 1)
gene was associated with low Lumbar Spine (LS) BMD,
FN BMD, and with osteoporotic fractures in subjects of
European and Asian descent [18].
To date, most studies examining the relationship of
SOST, MEF2C and JAG1 polymorphisms with BMD vari-
ation have been performed in populations of European
and Asian ancestry [4-6,10-12,18]. The aim of this study
was to analyze the possible association of polymorphisms




The study group included only women born in Mexico
whose parents and grandparents identified themselves as
Mexican Mestizos. This study was performed as part of
the third stage of a previously described, long-term co-
hort study [19,20]. A total of 400 unrelated postmeno-
pausal women over 45 years of age, without spontaneous
menses for at least 1 year, attending the Instituto Mexicano
del Seguro Social (IMSS) located in Cuernavaca, Morelos
State, were recruited. Exclusion criteria were a history of
bone, metabolic or endocrine disease, history of oophorec-
tomy prior to 45 years of age, menopause prior to 40 years
of age, or use of medication interfering with bone metab-
olism. Data on demographic characteristics and informa-
tion regarding smoking status, menopausal status,
estrogen use, medical history, and use of medication were
obtained from self-administered questionnaires. The study
was approved by the IMSS Research Ethics Committee
and all participants provided signed informed consent.
Blood samples were obtained and stored at 4°C until use.
Genomic DNA was extracted from the peripheral blood ofall participants, using a commercial isolation kit (QIAGEN
systems Inc., Valencia, CA), according to the manufac-
turer’s instructions.
Measurement of bone mineral density
BMD at the lumbar spine (L2-4), femoral neck, and
total hip were assessed using a dual X-ray absorpti-
ometry (DXA) Lunar DPX NT instrument (Lunar Radi-
ation Corp., Madison WI). BMD was calculated from
bone mineral content (g) and bone area (cm2), and then
expressed as g/cm2.
Genotyping and single nucleotide polymorphism selection
In an initial phase of the study, a GoldenGate platform
with a total of 384 SNPs was used to test for associations
with BMD, including twenty-five SOST and seven JAG1
SNPs [21]. These SNPs were selected using the following
criteria: minor allele frequency (MAF) >5% in Caucasians,
and polymorphisms previously associated with BMD in
candidate gene association studies, genome wide associ-
ation studies (GWAS) and meta-analyses [4,6,10-12,18].
Genotype data were extracted for further analysis.
In the present study, we extended the analysis to seek
other possible associations between SNPs and BMD va-
riation in another member of the Wnt signaling pathway,
the MEF2C gene, analyzing three SNPs (rs12521522,
rs11951031 and rs13665949). Furthermore, we geno-
typed five SOST SNPs (rs9911277, rs4793018, rs1983490,
rs1881107 and rs4792909), and three JAG1 SNPs
(rs2273061, rs6040061 and rs2235811) in 30% of ran-
domly selected samples. Genotyping of these eleven
SNPs was performed using commercial predesigned
TaqMan Probes (Applied Biosystems, Foster City, CA,
USA) in a StepOne Plus RT PCR system. Information
on the parental frequencies and genotype data for a
panel of 96 Ancestry Informative Markers (AIMs) was
extracted from the initial phase genotypes, in order to
control for the effect of false associations due to popula-
tion stratification.
Statistical analyses
All data from the population in the study are showed as
mean ± SD (standard deviation) for quantitative variables
and absolute and relative frequencies for qualitative vari-
ables. Hardy-Weinberg equilibrium was tested for each
SNP using the standard χ2 test. Linear regression analyses
were used in order to test for associations between BMD
and genotype using an additive genetic model adjusting
for age and body mass index (BMI). Ancestry from princi-
pal component analysis (PCA) was estimated using the
smartpca program in the Eigensoft 3.0 package [22], and
ancestry estimates were included as confounding factors
for correction of population stratification. All statistical
analyses were performed with Statistical Package for Social
Table 1 Demographic characteristics and BMD of
postmenopausal Mexican Mestizo women
Variable Mean (SD)
Age (Yr) 62.25 (9.11)
Height (cm) 152.98 (5.74)
Weight (Kg) 65.73 (11.74)
BMIa (Kg/m2) 28.08 (4.76)
BMDb total hip (g/cm2) 0.929 (0.133)
BMDb femoral neck (g/cm2) 0.880 (0.125)
BMDb lumbar spine (g/cm2) 0.990 (0.151)
Age of Menarche 12.94 (1.55)
Number of children 3.12 (2.13)
Duration of breastfeeding (months) 15.90 (19.86)
Years since menopause 17.84 (11.59)
Estrogen remplacement therapyc 110 (26.00)
Tobacco usec 137 (34.33)
Alcohol intakec 45 (11.26)
Carbonated beverage consumptionc 315 (78.75)
N = 400 Postmenopausal women.
aBMI = Body Mass Index.
bBMD = Bone Mineral Density.
cn (%); n, number of women; SD, standard deviation.
Table 2 Information on the SNPs analyzed in this study
Gene SNP Allele Position Location in the gene
MEF2C rs1366594 C/A 5:88376061 Intergenic
SOST rs9911277 G/A 17:41780484 Intergenic
rs4793018 C/T 17:41781069 Intergenic
rs1983490 G/A 17:41782957 Intergenic
rs1881107 A/G 17:41786076 Intergenic
rs4792909 G/T 17:41798824 Intergenic
JAG1 rs2273061 A/G 20:10639543 Intron variant
rs6040061 A/C 20:10640306 Intron variant
rs2235811 C/T 20:10644158 Intron variant
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USA). P-values <0.05 were considered statistically signifi-
cant. Linkage disequilibrium (LD) and haplotype frequen-
cies were estimated using Haploview 4.2 [23]. Statistical
power was calculated with Quanto 1.1 software, for a sig-
nificance level of 0.05 and MAF of 5% in 400 postmeno-
pausal women with a minimal power of 80% to detect
differences in BMD, under an additive model. The signifi-
cance threshold after multiple test correction for each
gene was estimated using the single nucleotide spectral
decomposition software (SNPSpD) [24]. This approach
can be applied to obtain an effective number of indepen-
dent marker loci (Meff). The application of SNPSpD to
our nine SNP sample set gave a Meff of 5.48 SNPs, leading
to a significance threshold of 0.05/5.48 = 0.009.
Results
The quality control (QC) criteria for subject and SNP
genotyping for the initial phase have been previously de-
scribed [21]. Briefly, data from 14 individuals whose
DNA did not genotype successfully were excluded and
11 more participants were discarded from subsequent
analysis because their African ancestry exceeded the
mean reported for the Mexican mestizo population [25].
In the second phase, the overall genotype call rate was
98%, and the genotypes showed 100% reproducibility
with those obtained in the initial phase. Two MEF2C
SNPs (rs12521522 and rs11951031) were not observed
in this sample of Mexican women, and were thus ex-
cluded from the analysis.
The general characteristics of the participating women
are presented in Table 1. Mean age was 62.25 ± 9.11 years,
and a mean BMI was 28.08 ± 4.76 kg/m2. Mean bone pa-
rameters were within normal range, although mean LS
BMD was 0.990 ± 0.151 (mild osteopenia), which is ex-
pected given the age of study participants.
In the initial stage, twenty-five SOST and seven JAG1
SNPs were tested for single-marker allelic association,
adjusting for age, body mass index (BMI) and ancestry
estimates. In the second phase, five SOST and three
JAG1 SNPs showing significant associations with BMD
were further analyzed. SNP details are described in Table 2.
Genotype and allele frequency distributions of all SNPs
did not differ from Hardy-Weinberg equilibrium (Table 3).
In the second phase, linear regression analyses adjusted
by age, BMI, and ancestry estimates showed that SOST
gene SNPs rs9911277, rs4793018, rs1983490, rs1881107
and rs4792909 were significantly associated with TH-
BMD and NF-BMD (mean effect size of −0.027 per risk
allele; lowest p value = 0.0012) but not with LS-BMD
(Table 4). MEF2C gene rs1366594 failed to show a signifi-
cant association with any BMD estimation (p value range
0.938 - 0.542). On the other hand, JAG1 gene SNPs
rs2235811 and rs2275811 showed a trend to associationwith FN-BMD and LS-BMD (p = 0.051 and 0.089, respect-
ively); well above the multiple test-significance threshold
estimated at 0.009. After correction for multiple testing,
only the association of BMD with SOST polymorphisms
remained significant.
Linkage disequilibrium analysis revealed significant rela-
tionships among the SOST gene polymorphisms, identifying
a single high LD block (pair-wise r2 values >0.89; Figure 1).
Significant LD was observed across the gene, and we in-
ferred the existence of two main haplotypes: ACAC and
CACA, with frequencies of 0.49 and 0.48, respectively.
Discussion
OP constitutes a serious and increasing public health
problem in the Mexican population [2]. To date, GWAS
Table 3 Genotype/allele frequencies and Hardy-Weinberg
equilibrium (HWE) P values for the analyzed SNPs
aSNP reference number Genotype N % bHWE
rs1366594 MEF2C C/C 186 46.6 p = 0.30
C/A 166 41.6
A/A 47 11.8
Allele frequency C 538 67.4
A 260 32.6
rs9911277 SOST G/G 113 28.6 p = 0.70
G/A 193 48.9
A/A 89 22.5
Allele frequency G 419 53.0
A 371 47.0
rs4793018 SOST C/C 117 29.5 p = 0.58
C/T 192 48.4
T/T 88 22.2
Allele frequency C 426 53.7
T 368 46.3
rs1983490 SOST G/G 121 30.3 p = 0.55
G/A 192 48.1
A/A 86 21.6
Allele frequency G 434 54.4
A 364 45.6
rs1881107 SOST A/A 122 30.7 p = 0.43
A/G 189 47.6
G/G 86 21.7
Allele frequency A 433 54.5
G 361 45.5
rs4792909 SOST G/G 116 29.2 p = 0.27
G/T 187 47.1
T/T 94 23.7
Allele frequency G 419 52.8
T 375 47.2
rs2273061 JAG1 A/A 132 33.2 p = 0.43
A/G 201 50.5
G/G 65 16.3
Allele frequency A 465 58.4
G 331 41.6
rs6040061 JAG1 A/A 147 37.1 p = 0.21
A/C 198 50.0
C/C 51 12.9
Allele frequency A 492 62.1
C 300 37.9
Table 3 Genotype/allele frequencies and Hardy-Weinberg
equilibrium (HWE) P values for the analyzed SNPs
(Continued)
rs2235811 JAG1 C/C 151 38.1 p = 0.43
C/T 193 48.7
T/T 52 13.1
Allele frequency C 495 62.5
T 297 37.5
aSNP = single nucleotide polymorphism; bHWE = Hardy-Weinberg Equilibrium.
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associated with BMD variation, but these studies have
been performed mostly in populations of European and
Asian ancestry [5,6]. In the present study, we analyzed
the association of polymorphisms of the MEF2C, SOST
and JAG1 genes with BMD variation in postmenopausal
Mexican-mestizo women.
We found that SNPs of the SOST gene were associated
with total hip and femoral neck, but not with lumbar
spine BMD. These results are consistent with recent
genome-wide association studies [4-6,11], and may be
explained at least partly by a lower heritability for BMD
in the femoral neck site. This is supported by a previous
study reporting that hip BMD of grandmothers is better
predictor of hip BMD in mothers (beta = 0.46); while
maternal LS BMD was less predictive of LS BMD in
grandchildren (beta = 0.30) [19].
Together, our findings support the association of Wnt
signaling pathway gene polymorphisms with BMD vari-
ation in the Mexican-mestizo population [21]. SOST is a
known Wnt signaling inhibitor, which acts suppressing
LRP function. In vitro, SOST inhibits osteoblast develop-
ment and is expressed primarily in osteocytes [26]. SOST
polymorphisms have been associated with BMD at dif-
ferent skeletal sites and with osteoporotic fractures in
various populations [10-12]. Our present finding of a
SOST-BMD association in the Mexican-mestizo popula-
tion is in agreement with a similar association found by
Estrada et al. [6] and Richards et al. [11] in postmeno-
pausal women of European ancestry.
The MAFs of SOST gene SNPs rs9911277, rs4793018,
rs1983490, and rs1881107 observed in the present study
were very similar to those reported in the HapMap in in-
dividuals of Mexican ancestry of Los Angeles (0.45 to
0.47), but were less frequent than in European popula-
tions (MAF: 0.35 to 0.38). On the other hand, the
rs4792909 “G” allele, most widely reported and associ-
ated with fracture risk in a large meta-analysis, was less
frequent in our population (0.53) than in Europeans
(0.62) [6], but very similar to that observed in a Los
Angeles population of Mexican ancestry (0.53), (http://
hapmap.ncbi.nlm.nih.gov).
Table 4 Association of MEF2C, SOST and JAG1 polymorphisms with BMD in postmenopausal Mexican-women
Gene dbSNP β (95% IC)d padjust
e
BMD-THa (g/cm2) MEF2C rs1366594 0.001 (−0.016; 0.017) 0.938
SOST rs9911277 −0.031 (−0.046; −0.016) 0.000072
rs4793018 −0.027 (−0.043; −0.012) 0.00035
rs1983490 −0.027 (−0.042; −0.012) 0.00040
rs1881107 −0.027 (−0.042; −0.011) 0.00055
rs4792909 −0.025 (−0.040; −0.010) 0.0012
JAG1 rs2273061 0.007 (−0.009; 0.023) 0.409
rs6040061 0.009 (−0.007; 0.026) 0.280
rs2235811 0.011 (−0.005; 0.027) 0.189
BMD-FNb (g/cm2) MEF2C rs1366594 0.004 (−0.011; 0.019) 0.638
SOST rs9911277 −0.029 (−0.043; −0.015) 0.000048
rs4793018 −0.026 (−0.040; −0.012) 0.00024
rs1983490 −0.027 (−0.041; −0.013) 0.00018
rs1881107 −0.026 (−0.040; −0.012) 0.00027
rs4792909 −0.025 (−0.039; −0.011) 0.00053
JAG1 rs2273061 0.007 (−0.008; 0.022) 0.331
rs6040061 0.013 (−0.003; 0.028) 0.109
rs2235811 0.013 (−0.002; 0.028) 0.089
BMD-LSc (g/cm2) MEF2C rs1366594 0.007 (−0.015; 0.028) 0.542
SOST rs9911277 −0.006 (−0.027; 0.014) 0.539
rs4793018 −0.007 (−0.027; 0.013) 0.498
rs1983490 −0.007 (−0.027; 0.014) 0.514
rs1881107 −0.003 (−0.023; 0.018) 0.806
rs4792909 −0.002 (−0.022; 0.019) 0.865
JAG1 rs2273061 0.021 (0.000; 0.042) 0.051
rs6040061 0.008 (−0.014; 0.030) 0.484
rs2235811 0.007 (−0.015; 0.028) 0.557
aBMD-TH = Total hip bone mineral density.
bBMD-FN = Femoral neck bone mineral density.
cBMD-LS = Lumbar spine bone mineral density.
dData are shown for the additive model.
ep-adjust values were adjusted by age, BMI, and ancestry estimates.
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specific MEF2C and JAG1 SNPs and BMD variation previ-
ously identified in populations of European and Asian an-
cestry [4,5,18]. The MEF2C rs1366594 “A” allele was not
associated with BMD variation in the present study, and
was less frequent in Mexican postmenopausal women
(0.33) than in Europeans (0.55), East-Asians (0.42) and
Han Chinese individuals (0.40) [4,5,27]. Moreover, the
MEF2C rs11951031 previously associated with forearm
BMD in Europeans and individuals of Mexican-American
descent was not informative in this sample of Mexican
menopausal women. This may be partially explained by
our sample size being too small to detect a risk allele with
a frequency of 0.06 [16].
Similarly, we failed to observe associations of JAG1
polymorphisms with BMD variation. JAG1 rs2273061 wasinitially found to be associated with BMD variation (LS
and FN) in a GWAS performed in Hong Kong Chinese in-
dividuals, and this association was afterwards confirmed
in several European populations [18]. However, this SNP
was not associated with BMD variation in a Mexican-
Mestizo cohort [28], in consistency with our present ob-
servations. Moreover, the JAG1 rs2273062 allelic and
genotypic frequencies reported here are virtually identical
to those described previously in Mexicans [28], and the
“G” allele frequency (0.42) was similar to that reported in
Europeans (0.40), but higher than in the population of
Hong Kong (0.31) [18]. The rs2235811 and rs6040061
MAFs observed in Mexican postmenopausal women were
similar to those published in the dbSNP database for a
population of Asian descent (http://www.ncbi.nlm.nih.gov/
SNP/). However, it is notable that although Kung et al.
Figure 1 Location and pair-wise linkage disequilibrium values of SOST and JAG1 polymorphisms in Mexican postmenopausal women.
Darker color indicates higher LD and lighter color indicates less LD. Values of the pair-wise (r2) are shown to SOST (a) and JAG1 (b) genes.
Velázquez-Cruz et al. BMC Musculoskeletal Disorders 2014, 15:400 Page 6 of 8
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high LD in individuals of both Chinese (r2 > 0.9) and
European (r2 > 0.7, CEU) descent [18], in our population
rs2273061 was clearly not in LD with the other JAG1 poly-
morphisms (Figure 1). This may explain why rs2273061
was not associated with BMD in this study. Further
studies including other JAG1 SNPs will define whether
this gene is associated with BMD or not in the Mexican
population.
The Mexican population is admixed and has a complex
genetic structure including European, Native American
and a small proportion of African genes [29,30]. Spurious
association signals produced by differences in ancestral
background can be a confounding factor in genetic associ-
ation studies [31,32]. Since population stratification may
be a source of spurious associations, we used the first and
second principal component from PCA, described pre-
viously [21] to account for population stratification. Our
results suggest that population stratification was most
likely not a confounding factor in this study.
Our study has some limitations. First, MEF2C, JAG1
and SOST SNPS were selected based on previous reports
from European and Asian populations, and thus other
SNPs within the same genes may contribute to BMD
variation in Mexican-mestizos. Second, the failure to ob-
serve associations of MEF2C and JAG1 SNPs with BMD
in our population may be due to the small sample size
and reduced statistical power of the study [33]. Although
our sample size (400 individuals) was large enough to
identify the effect of SOST gene variants on BMD, in
order to replicate the previously observed association of
MEF2C rs1366594, considering a MAF of 0.33 and an
effect size of 0.08 (in standard deviations of BMD), a
total of 2,769 samples would be needed to achieve 80%statistical power to detect a significant association. The
statistical power of the present study to find a significant
association with this SNP was only 19%. Similarly, we
would require 6,909 samples to obtain adequate statis-
tical power to detect an association of JAG1 rs2273061
with BMD variation, considering a MAF of 0.42 and an
effect size of 0.048 SDs. Thus, even the combined results
of the present study with those of Rojano-Mejía et al.,
who genotyped the rs2273061 in 750 Mexican individ-
uals, would not reach adequate statistical power to repli-
cate the association of this SNP with BMD. These
results should be interpreted with caution, and should
be considered as uncertain rather than null associations.
Additional studies in larger samples are required to
understand the role of MEF2C and JAG1 gene variation
in BMD variation in the Mexican population.
Conclusions
In conclusion, our results suggest that SOST polymor-
phisms contribute to total hip and femoral neck BMD
variation in postmenopausal Mexican-mestizo women.
Taken together, these and other previously reported
findings in the Mexican population suggest that vari-
ation in genes located in the Wnt pathway may be im-
portant contributors to BMD variation in the Mexican-
mestizo population. Further investigation is required to
understand interactions of genes located in this pathway
with other factors, such as hormones and nutrition.
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